Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women

Hypertension Research

Volumn 25, Issue 2, 2002, Pages 153-159

  Miya, Yoshinori ^a   Sumino, Hiroyuki ^a   Ichikawa, Shuichi ^a   Nakamura, Tetsuya ^a   Kanda, Tsugiyasu ^a   Kumakura, Hisao ^a   Takayama, Yoshiaki ^a   Mizunuma, Hideki ^a   Sakamaki, Tetsuo ^a   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Estrogen; Hypertension; Hypertrophy; Regression; Women

Indexed keywords

ALDOSTERONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; FOLLITROPIN; FUROSEMIDE; GLUCOSE; GLUCOSE OXIDASE; GROWTH FACTOR; HIPPURIC ACID; INSULIN; MEDROXYPROGESTERONE ACETATE; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INSULIN RESISTANCE; M MODE ECHOCARDIOGRAPHY; POSTMENOPAUSE;

ALDOSTERONE; ECHOCARDIOGRAPHY; ESTROGEN REPLACEMENT THERAPY; FEMALE; GROWTH SUBSTANCES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POSTMENOPAUSE;

EID: 0036236531     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.153     Document Type: Article

References (39)

1. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
2. Left ventricular hypertrophy in hypertension: Stimuli, patterns, and consequences
3. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
4. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
5. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
6. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study
7. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women: The CARDIA study: Coronary Artery Risk Development in Young Adults
8. Effect of hormone replacement therapy on left ventricular hypertrophy
9. Exercise echocardiograph in postmenopausal hormone users with mild systemic hypertension
10. Effects of transdermal 17β-estradiol on left ventricular anatomy and performance in hypertensive women
11. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
12. Hormone replacement therapy and serum angiotensin-enzyme activity in postmenopausal women
13. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
14. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
15. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
16. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method
17. Recommendations concerning use of echocardiography in hypertension and general population research
18. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
19. Colorimetry of angiotensin-1 converting enzyme activity in serum
20. Reduction in left ventricular mass during treatment of essential hypertension is associated with improved prognosis
21. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy: Multicenter trial
22. The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension
23. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women
24. Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension: Dippers and peakers
25. Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes
26. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass
27. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
28. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension
29. Insulin resistance is an important determinant of left ventricular mass in the obese
30. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome
31. Myocardial wall thickness and left ventricular geometry in hypertensives: Relationship with insulin
32. Mechanisms of insulin resistance in human obesity
33. Insulin-like growth factor-I induces cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes
34. Inhibition of cardiomyocyte hypertrophy by estrogen
35. 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth
36. Cardiac myocytes and fibroblasts contain functional estrogen receptors
37. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women
38. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension
39. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women